comparemela.com

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Free Report) – Zacks Small Cap raised their FY2024 earnings per share (EPS) estimates for shares of Rani Therapeutics in a research note issued on Thursday, March 21st. Zacks Small Cap analyst J. Vandermosten now anticipates that the company will post earnings of ($1.00) per share for the year, […]

Related Keywords

,Nasdaq ,Rani Therapeutics Holdings Inc ,Millennium Management ,Goldman Sachs Group Inc ,Vanguard Group Inc ,Blackrock Inc ,Rani Therapeutics Holdings ,Free Report ,Zacks Small Cap ,Rani Therapeutics ,Small Cap ,Rani Therapeutic ,Therapeutics Stock Down ,Street Corp ,Sachs Group ,Get Free Report ,Therapeutics Holdings ,Rani Therapeutics Daily ,Nasdaq Rani ,Rani ,Medical ,Earnings Estimates ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.